Multibagger MNC Pharma Stock Fixes Record Date To Pay 400% Final Dividend, Zero Debt Burden

Leading MNC Pharmaceuticals company AstraZeneca Pharma Ltd has fixed record date to pay 400% equity dividend to its shareholders. AstraZeneca India was established in 1979 and is headquartered at Bengaluru, Karnataka. Check the details below to receive dividend:

AstraZeneca Pharma Ltd to pay 400% dividend

Record date and ex-dividend date: The company's board had earlier approved an equity dividend of 400% earlier this year on 26 May, 2022. The record date has been fixed 8 July, 2022 and ex-dividend date is 7 July.

According to the company's BSE filing, "Further to our intimation dated May 26, 2022, we wish to inform that the Record Date for determining the entitlement of the shareholders for the payment of the Final Dividend for financial year 2021-22 is July 8, 2022. The Final Dividend, if approved by the shareholders, shall be paid/dispatched to the shareholders on or before September 6, 2022."

AstraZeneca Pharma Ltd stock outlook

The current market price of the stock is Rs 2698 apiece with a 52-week high of Rs 3674.95 apiece and a 52-week low of Rs 2437 apiece. The PE of the stock is Rs 109 which is higher than the sector PE of 29.01. When compared with its peers, AstraZeneca has highest TTM PE. The company has an ROE at 12.04%. It has an EPS of 24.64. It has a market capitalization of Rs 6712 crore.

Returns: The stock has given a negative return of 25% in one year and positive return of 193% in 5 years.

AstraZeneca Pharma Ltd dividend history

AstraZeneca has declared an equity dividend of 500% amounting to Rs 10 per share for the year ending March 2022. The dividend yield is 0.37 if the current market price of Rs 2698 is considered. The company has a good dividend track record and declared dividend for the past 5 years without fail. On 26 May, 2022 it had declared an equity dividend of 400% amounting to Rs 8 per share.

AstraZeneca Pharma Ltd overview

The company has reported a surge of 14% in its QoQ revenue growth at Rs 235 crore, highest in 3 years. AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization, according to its website.